glycopyrronium Topical Wipes
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Hyperhidrosis
Conditions
Hyperhidrosis
Trial Timeline
Aug 1, 2015 → Apr 1, 2016
NCT ID
NCT02530294About glycopyrronium Topical Wipes
glycopyrronium Topical Wipes is a phase 3 stage product being developed by Journey Medical for Hyperhidrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02530294. Target conditions include Hyperhidrosis.
What happened to similar drugs?
0 of 5 similar drugs in Hyperhidrosis were approved
Approved (0) Terminated (0) Active (5)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02553798 | Phase 3 | Completed |
| NCT02530294 | Phase 3 | Completed |
| NCT02530281 | Phase 3 | Completed |
Competing Products
14 competing products in Hyperhidrosis